➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKinsey
Dow
Baxter
Johnson and Johnson

Last Updated: October 20, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: mesalamine


Email this page to a colleague

« Back to Dashboard

MESALAMINE

CASRN: 89-57-6

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKinsey
Dow
Boehringer Ingelheim
Merck